110 related articles for article (PubMed ID: 1445360)
21. Inhibiting long chain fatty Acyl CoA synthetase increases basal and agonist-stimulated NO synthesis in endothelium.
Weis MT; Crumley JL; Young LH; Stallone JN
Cardiovasc Res; 2004 Aug; 63(2):338-46. PubMed ID: 15249192
[TBL] [Abstract][Full Text] [Related]
22. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor.
Triggiani M; Connell TR; Chilton FH
J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931
[TBL] [Abstract][Full Text] [Related]
23. Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes.
Stewart AG; Harris T
J Lipid Mediat; 1991; 3(2):125-38. PubMed ID: 1665713
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting long-chain fatty acyl CoA synthetase does not increase agonist-induced release of arachidonate metabolites from human endothelial cells.
Weis MT; Brady M; Moore M; Crumley J; Stallone JN
J Vasc Res; 2005; 42(4):275-83. PubMed ID: 15908751
[TBL] [Abstract][Full Text] [Related]
25. Evidence for an essential role of long chain acyl-CoA synthetase in animal cell proliferation. Inhibition of long chain acyl-CoA synthetase by triacsins caused inhibition of Raji cell proliferation.
Tomoda H; Igarashi K; Cyong JC; Omura S
J Biol Chem; 1991 Mar; 266(7):4214-9. PubMed ID: 1999415
[TBL] [Abstract][Full Text] [Related]
26. Synergistic effect of thromboxane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils.
Kishino J; Hanasaki K; Kato T; Arita H
Biochim Biophys Acta; 1991 Apr; 1092(2):169-74. PubMed ID: 1673352
[TBL] [Abstract][Full Text] [Related]
27. Complete inhibition of mouse macrophage-derived foam cell formation by triacsin C.
Namatame I; Tomoda H; Arai H; Inoue K; Omura S
J Biochem; 1999 Feb; 125(2):319-27. PubMed ID: 9990129
[TBL] [Abstract][Full Text] [Related]
28. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor.
Pinckard RN; Showell HJ; Castillo R; Lear C; Breslow R; McManus LM; Woodard DS; Ludwig JC
J Immunol; 1992 Jun; 148(11):3528-35. PubMed ID: 1316919
[TBL] [Abstract][Full Text] [Related]
29. A sensitive and specific radioimmunoassay for platelet-activating factor.
Wang C; Tai HH
Lipids; 1992 Mar; 27(3):206-8. PubMed ID: 1522765
[TBL] [Abstract][Full Text] [Related]
30. Characterization of triacsin C inhibition of short-, medium-, and long-chain fatty acid: CoA ligases of human liver.
Vessey DA; Kelley M; Warren RS
J Biochem Mol Toxicol; 2004; 18(2):100-6. PubMed ID: 15122652
[TBL] [Abstract][Full Text] [Related]
31. Influence of isoproterenol and phosphodiesterase inhibitors on platelet-activating factor biosynthesis in the human neutrophil.
Fonteh AN; Winkler JD; Torphy TJ; Heravi J; Undem BJ; Chilton FH
J Immunol; 1993 Jul; 151(1):339-50. PubMed ID: 8392098
[TBL] [Abstract][Full Text] [Related]
32. 1-Acyl-2-acetyl-sn-glycero-3-phosphocholine from stimulated human polymorphonuclear leukocytes.
Satouchi K; Oda M; Saito K
Lipids; 1987 Apr; 22(4):285-7. PubMed ID: 3110532
[TBL] [Abstract][Full Text] [Related]
33. Triacsin C blocks de novo synthesis of glycerolipids and cholesterol esters but not recycling of fatty acid into phospholipid: evidence for functionally separate pools of acyl-CoA.
Igal RA; Wang P; Coleman RA
Biochem J; 1997 Jun; 324 ( Pt 2)(Pt 2):529-34. PubMed ID: 9182714
[TBL] [Abstract][Full Text] [Related]
34. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
Bauldry SA; Wykle RL; Bass DA
Biochim Biophys Acta; 1991 Jul; 1084(2):178-84. PubMed ID: 1854803
[TBL] [Abstract][Full Text] [Related]
35. Alkyl-PAF and acyl-PAF human neutrophil priming for enhanced fMLP- and rC5a-induced superoxide anion production.
Pinckard RN; Prihoda TJ
J Leukoc Biol; 1996 Feb; 59(2):219-28. PubMed ID: 8603994
[TBL] [Abstract][Full Text] [Related]
36. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
[TBL] [Abstract][Full Text] [Related]
37. Enhancement by staurosporine of platelet-activating factor formation in N-formyl peptide-challenged human neutrophils is mediated by intracellular platelet-activating factor binding sites.
Müller S; Nigam S
Biochem Biophys Res Commun; 1992 Dec; 189(2):771-6. PubMed ID: 1335246
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate.
Shintani M; Nishimura H; Yonemitsu S; Masuzaki H; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Nakao K
Metabolism; 2000 Mar; 49(3):326-30. PubMed ID: 10726909
[TBL] [Abstract][Full Text] [Related]
39. Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide.
Svetlov SI; Liu H; Chao W; Olson MS
Biochim Biophys Acta; 1997 Jun; 1346(2):120-30. PubMed ID: 9219895
[TBL] [Abstract][Full Text] [Related]
40. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine.
Wirthmueller U; De Weck AL; Dahinden CA
J Immunol; 1989 May; 142(9):3213-8. PubMed ID: 2540238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
